Dashboard
1
With a growth in Net Sales of 8.46%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at SAR 842.69 MM
- ROCE(HY) Highest at 24.86%
- INTEREST COVERAGE RATIO(Q) Highest at 1,862.11
2
With ROE of 22.50%, it has a very attractive valuation with a 3.99 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
SAR 11,520 Million (Small Cap)
18.00
NA
2.08%
0.01
22.50%
3.89
Revenue and Profits:
Net Sales:
792 Million
(Quarterly Results - Dec 2025)
Net Profit:
138 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.59%
0%
-16.59%
6 Months
-16.02%
0%
-16.02%
1 Year
5.57%
0%
5.57%
2 Years
102.19%
0%
102.19%
3 Years
197.68%
0%
197.68%
4 Years
290.49%
0%
290.49%
5 Years
783.97%
0%
783.97%
Astra Industrial Group for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.44%
EBIT Growth (5y)
24.53%
EBIT to Interest (avg)
8.30
Debt to EBITDA (avg)
0.55
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.96
Tax Ratio
11.61%
Dividend Payout Ratio
41.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.01%
ROE (avg)
17.20%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
3.99
EV to EBIT
17.05
EV to EBITDA
15.24
EV to Capital Employed
3.96
EV to Sales
3.86
PEG Ratio
0.84
Dividend Yield
2.03%
ROCE (Latest)
23.21%
ROE (Latest)
22.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
791.80
730.10
8.45%
Operating Profit (PBDIT) excl Other Income
142.40
202.50
-29.68%
Interest
11.20
10.90
2.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
138.20
167.30
-17.39%
Operating Profit Margin (Excl OI)
151.20%
249.40%
-9.82%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 8.45% vs 2.10% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -17.39% vs -11.48% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,070.70
3,062.30
0.27%
Operating Profit (PBDIT) excl Other Income
770.80
734.70
4.91%
Interest
50.80
107.30
-52.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
666.60
552.90
20.56%
Operating Profit Margin (Excl OI)
226.20%
215.00%
1.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.27% vs 8.61% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 20.56% vs 14.21% in Dec 2024
About Astra Industrial Group 
Astra Industrial Group
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






